HOME INFUSION THERAPY MARKET ANALYSIS

Home Infusion Therapy Market Size and Trends

The global home infusion therapy market is estimated to be valued at USD 24.51 Bn in 2024 and is expected to reach USD 38.4 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.

Discover market dynamics shaping the industry: Request sample copy

The home infusion therapy market is expected to witness high growth rate over the forecast period owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. Rising geriatric population suffering from these conditions coupled with growing preference of patients to get treatment administered at home instead of hospitals or long-term care centers is a key factor expected to drive the demand for home infusion therapy. Additionally, rising health care costs have compelled patients to opt for low-cost treatment settings like home care which is further expected to support the market growth in the coming years.

Growing Prevalence of Chronic Diseases

There has been a consistent rise in the number of patients suffering from chronic diseases across the globe. Some of the most common chronic diseases include cancer, diabetes, cardiovascular diseases, respiratory diseases, and autoimmune disorders. According to experts, numerous factors such as increasing sedentary lifestyles, unhealthy diets, rising stress levels, pollution, and increasing geriatric population are contributing to this trend. Chronic diseases require long term treatment and management and many a times patients require medications and therapies to be administered at home. Home infusion therapy market provides an effective solution for patients with chronic diseases to receive intravenous medication, nutrition, or other therapies in the comfort of their home. This helps in improving their quality of life by relieving them from frequent hospital visits. With a greater number of people being diagnosed with chronic diseases each year, the demand for alternative treatment options like home infusion therapy market is growing worldwide. For instance, according to data from the World Health Organization (WHO) in the Global Tuberculosis Report 2021, the majority of tuberculosis cases were concentrated in the WHO regions of South-East Asia (43%), Africa (25%), and the Western Pacific (18%). Similarly, based on WHO data from 2021, Sub-Saharan Africa bears a significant burden of malaria, with 95% of all infections occurring in this region, indicating a continued heavy impact from the disease. Consequently, the increasing burden of various infectious diseases across developed and emerging markets is expected to propel growth in the market under study.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

Advancements in Home Infusion Technologies

Over the years, significant developments have been made in home infusion technologies which have made therapy more viable, safe, and convenient for patients. The development of small, portable infusion pumps and devices have allowed complex drug regimens and treatments to be administered outside of hospitals. These pumps are programmable, lightweight, and equipped with alarms to prevent any medication errors. Advancements in catheter and vascular access technologies have minimized the risks of infections and other complications associated with the delivery of infused medicines at home. This has encouraged more physicians to prescribe infusion treatments at home. New innovations in connectivity technologies are also allowing remote monitoring of patients via mobile apps and internet. Caregivers can now seamlessly track patients' vital signs and infusion status from a distance. Emerging technologies like artificial intelligence and robotics are further enhancing the reliability and ease of use of home infusion equipment. Such technological breakthroughs have addressed various concerns around home infusion and built confidence among doctors to transition eligible patients from hospital care to homes. This serves as a major driver enabling growth in home infusion therapy adoption.

Key Takeaways from Analyst:

The global home infusion therapy market is expected to experience significant growth in the coming years. One of the key drivers for this growth is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases globally. As these diseases require long-term treatment and medication, home infusion therapy offers an effective solution for patients' treatment and management. Furthermore, the growing geriatric population prone to chronic illnesses will also accentuate market growth.

However, stringent regulations around home infusion practices in various countries may hinder the market expansion to some extent. Availability of alternative treatment settings such as hospital stays or ASCs also pose a challenge. Lack of knowledge about treatment options among patients particularly in emerging nations further restrict the market growth.

The Asia Pacific region is expected to dominate the global home infusion therapy market during the forecast period. This is due to rising healthcare expenditures, increasing awareness about home infusion benefits, and growing prevalence of chronic diseases. North America will continue its stronghold as the largest market. Meanwhile, Latin America will offer lucrative opportunities for market players owing to the growing medical tourism industry and the emergence of low-cost manufacturers. In Europe, favorable regulations and reimbursement coverage are supporting sustained market growth.

Market Challenges: Risk of infections associated with infusion therapy

The risk of infections associated with infusion therapy continues to be a major concern for patients opting for home infusion treatment. Infusion-related bloodstream infections can lead to serious health complications and sometimes even result in mortality. While hospitals have robust protocols and sterile environments to minimize such risks, maintaining similar hygiene and safety standards at home can be challenging. Many patients and their families fear that common home settings may not fully limit the risk of contamination in IV lines, catheters or infusion pumps. This makes them hesitant in accepting long-term infusion regimens involving frequent visits by nursing staff at home. The ongoing COVID-19 pandemic has further heightened infection-related anxieties among vulnerable patients and caregivers. As per the data shared by the US Centers for Disease Control and Prevention in May 2022, immunocompromised individuals face 3-5 times higher risk of severe COVID-19 illness and outcomes. This covers many patients requiring long-term infusion therapies for chronic conditions like cancer, multiple sclerosis, etc.

Market Opportunities: Development of novel infusion systems and services

The development of novel infusion systems and services has the potential to unlock great opportunities in the home infusion therapy market. Traditionally, infusion therapy involved patients having to travel regularly to hospitals or clinics to receive their treatment. This placed stress on patients and their families as well as placing a burden on healthcare systems. However, new technologies now allow for customized infusion regimens to be administered at home with minimal clinician oversight. Advanced infusion devices come with sophisticated software that allows healthcare providers to remotely monitor patients in real-time. Dosages can be programmed and adjusted as needed based on the individual's condition and response to treatment. Additionally, home health aides can be trained on the proper use of equipment to ensure treatment is delivered safely and effectively. This shift to home-based care enables greater convenience for patients while freeing up resources at medical facilities. It also empowers individuals to receive lifesaving therapies while maintaining their work, family, and social responsibilities.

Discover high revenue pocket segments and roadmap to it: Request sample copy

Insights By Product Type: Infusion Pumps: A Key Growth Driver

In terms of product type, the infusion pumps segment is expected to contribute the highest share of the global home infusion therapy market with 40.2% in 2024 owing to their versatility and suitability for delivering a variety of therapies at home. Infusion pumps allow for precision in drug delivery directly into the body via an IV, offering patients greater autonomy and control over their treatment. The demand for infusion pumps is primarily driven by their widespread application in chemotherapy and diabetes treatment. For chemotherapy patients, infusion pumps enable convenient home-based administration of drugs over extended periods, significantly improving quality of life by reducing hospital visits. They also help regulate drug dosage more accurately compared to manual methods. Similarly, insulin-dependent diabetes patients rely on infusion pumps to maintain steady glucose levels outside of hospital settings. Advanced pump features like customizable basal rate programs and integrated glucose monitors facilitate remote monitoring by healthcare providers as well. Miniaturization of infusion pump technology has further increased acceptability among patients looking for discreet, wearable devices. Smaller pumps with longer battery lives can be discreetly concealed under clothing. Mems’s sensor-based smart pumps are also gaining traction due to integration of connectivity options. This allows two-way data transmission to cloud-based patient portals for better therapeutic management and oversight by physicians from a distance. Overall, the growing need for convenient, precise home-based therapies will continue augmenting the role of infusion pumps in home infusion services.

Insights By Application: Chemotherapy Drives Adoption

Among various application, chemotherapy is expected to account for the largest share of the home infusion therapy market with 30.12% in 2024 owing to the rising cancer prevalence and increasing shift towards home-based treatment. While hospital-based chemotherapy continues as the mainstream approach, many oncologists are now recommending interim home infusion to reduce clinic visits and improve patient comfort. The main advantages of home chemotherapy include avoidance of hospital-acquired infections, minimized disruptions to lifestyle and work, and more personalized care from family members. This is proving especially beneficial for older and palliative care patients requiring long-term treatment. With infusions being administered at a comfortable home setting by trained nurses, patients often experience less anxiety, pain and chemo-related side effects compared to clinical surroundings. At the same time, technological advancements are improving the safety, convenience, and monitoring ability of home chemotherapy. Smart pumps with integrated touchscreens help optimize dosage schedules and maintain accurate records of past infusions without manual errors. Connected health solutions provide real-time diagnostic data transmission to oncology teams to enable remote symptom tracking and early medical intervention if required.

Regional Insights

To learn more about this report, Request sample copy

North America remains the dominant region in the global home infusion therapy market. The region is expected to account for a share of 39.3% in 2024. With the majority of key industry players headquartered in the U.S., North America boasts of a strong industry presence and expertise in home infusion services. Several large hospitals and healthcare facilities in the U.S. offer patients access to specialized home nursing services for infusion therapy. This enables patients requiring long term infusion treatments to receive care safely and effectively at home, improving access, and affordability of care. Furthermore, favorable reimbursement policies from both public and private payers in the region encourage the use of home infusion therapy.

Asia Pacific has emerged as the fastest growing regional market for home infusion globally. Countries such as China, India, and Japan are witnessing a rapidly expanding population base of aging individuals as well as rising incidence of chronic diseases requiring long term infusion treatment regimens. This has driven the increased demand for home infusion solutions across Asia Pacific. With improving standards of medical infrastructure and growing medical tourism, several countries in the region are investing heavily to develop sustainable home healthcare models. This includes training nursing staff in infusion therapy application and partnering with device and equipment suppliers. As a result, Asia Pacific presents lucrative opportunities for providers to expand their geographical footprint. Favorable pricing of home infusion services compared to inpatient care also makes it an affordable option for both patients and national healthcare budgets.

Market Report Scope

Home Infusion Therapy Industry News

• In January 2023, KORU Medical Systems, Inc. a developer and manufacturer of medical devices, forged a development agreement with a pharmaceutical manufacturer specializing in subcutaneous immunoglobulin therapy (SCIg). The collaboration aims to create and seek regulatory approval for an enhanced version of the Freedom Infusion System featuring a prefilled SCIg syringe. The existing Freedom Infusion System includes the Freddom60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets, designed for administering infusions in home and alternative care settings.
• In September 2022, Baxter International Inc. American multinational healthcare company obtained FDA 510(k) clearance for its Novum IQ syringe infusion pump (SYR) equipped with Dose IQ Safety Software. This development represents Baxter's latest advancement in infusion therapy technology.
• In May 2023, Fresenius Kabi, a global healthcare company, entered into an agreement with Premier, Inc., an American healthcare company, resulting in pricing and term advantages for the Ivenix Infusion System. This system aims to enhance the reliability and ease of use of infusion pumps.
• Also in May 2023, Option Care Health, a healthcare service provider, partnered with Amedisys Inc., a leading home health services provider, to establish an independent platform for home care services. This platform includes pharmacists, dieticians, therapists, social workers, and other professionals, offering high-quality healthcare services directly at home.
• In April 2023, CareFusion, now under Becton Dickinson, an American medical technology company, introduced advanced ultrasound technology designed to improve IV insertions for clinicians. Given that more than 90% of hospitalized patients require IV therapy, this innovation is expected to contribute to the growth of the home infusion therapy market.

*Definition: The global home infusion therapy market provides the intravenous administration of drugs or nutrients directly into a patient's system, usually at home. It is an alternative to the administration and management of infusion therapy in a hospital inpatient setting. Home infusion therapy services include nursing support, care coordination, product delivery, and additional services including high-tech services like chemotherapy or antibiotic therapy. It allows patients to receive treatments normally given in healthcare facilities via IV, but in the comfort of their own home while being monitored remotely.

Market Segmentation

•  Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Infusion Pumps
    • Ambulatory Infusion Pumps
    • Insulin Pumps
    • Syringe Pumps
    • Elastomeric Pumps
    • Patient Controlled Analgesics (PCA)
    • Volumetric Pumps
  • Intravenous Set
  • IV Cannulas
  • Needleless Connectors
•  Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Chemotherapy
  • Diabetes
  • Hydration Therapy
  • Pain Management
  • Post-transplant Therapies
  • Parenteral Nutrition Therapy
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical
  • CareCentrix, Inc.
  • Coram CVS/specialty infusion services
  • Option Care Health Inc.
  • CVS Health
  • UnitedHealth Group (Optum)
  • McKesson Corporation
  • PharMerica Corporation
  • BioScrip, Inc.
  • MedicoRx Specialty Pharmacy
  • Infusystem
  • Diplomat Pharmacy, Inc.
  • Accredo Health Group, Inc.
  • Healix, Inc.
  • PromptCare Home Infusion